DYOR, it seems that from the responses so far we're getting very close to the 5M block, which is encouraging.
In regard to your question "Has there been any interest to buy the product outright" ...... could we add to that "has there been any interest in a partnership agreement from a major pharmaceutical company?" I remember several years ago that Mesoblast received a very substantial cash injection from such an arrangement and subsequently the share price increased tenfold.
Even though it would mean we'd have to share the eventual profits, I for one would be supportive of such a partnership as the alternative is going to be a large capital raising at a low price causing massive dilution. I'd estimate a doubling of outstanding shares to fund us through to completion of FDA trials as income from Europe won't be happening for quite some time. If all agree it would be worth considering encouraging management to consider this option when we submit our questions. It'd be good if we could get Allan Gray on board with this.
TIS Price at posting:
11.5¢ Sentiment: Hold Disclosure: Held
